| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 2.51 Billion |
| Market Size (2030) | USD 3.68 Billion |
| CAGR (2025 - 2030) | 8.01% |
| Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
France Patient Monitoring Market Analysis
The France Patient Monitoring Market size is estimated at USD 2.51 billion in 2025, and is expected to reach USD 3.68 billion by 2030, at a CAGR of 8.01% during the forecast period (2025-2030).
Factors such as the rising burden of chronic diseases and technological advancements in the products are boosting market growth. Chronic diseases such as cancers and cardiovascular diseases increase the demand for patient monitoring devices as abnormalities in vital signs can be observed in these conditions. For instance, according to data published by the International Agency for Research on Cancer in February 2024, the number of new cancer cases in France was reported to be 484 thousand in 2022, which is expected to reach 500 thousand by 2025 in the country. The anticipated rise in cancer cases will drive the demand for patient monitoring devices, fueling market expansion.
A high percentage of the senior population in the country is likely to contract various chronic diseases such as cancer, cardiovascular diseases, diabetes, hypertension, respiratory changes, and other diseases due to lifestyle and environmental changes. This is expected to increase the adoption of monitoring devices to regularly monitor their condition and status, thereby propelling the market's growth. For instance, data from the World Population Dashboard revealed that in 2024, France's population aged 65 and above constituted a notable 22% of the total, marking a significant demographic trend and is expected to rise over the coming years.
Furthermore, through partnerships and agreements, the companies are actively working on developing advanced patient monitoring devices. These efforts are expected to boost the availability of innovative devices and drive market growth during the forecast period. For instance, in November 2022, BIOSENCY partnered with RestMed to expand its offerings in France. Under this partnership, in France, RestMed distributed BIOSENCY's Bora-Care, a telemonitoring device for homecare patients with respiratory insufficiency.
Therefore, the market studied is poised for growth during the forecast period, driven by factors like the aging population and a rising burden of chronic diseases. However, the high cost of technology is likely to impede the growth of the patient monitoring market in France over the forecast period.
France Patient Monitoring Market Trends
The Neurology Segment is Expected to Show Healthy Growth in the Market Studied During the Forecast Period
The neurology segment is expected to witness significant growth in the patient monitoring market over the forecast period owing to factors such as the rising prevalence of neurological disorders such as Parkinson's, Alzheimer's, and dementia, the need to monitor neurological conditions regularly, and growing company activities in developing devices that help monitor brain activity.
The rising burden of neurological diseases among the population is the key factor driving the demand for neuromonitoring devices. For instance, the French Ministry of Health and Prevention, in April 2023, stated that around 272,500 patients in France suffer from Parkinson's, and 25,000 new cases are reported each year. This shows the high burden of neurological diseases such as Parkinson's, which can be monitored for loss of balance and slow movements, and increases the need for monitoring devices in the country.
Furthermore, the increasing product launches in the country may augment the availability of neuromonitoring devices in the market, which is expected to boost segment growth. For instance, in March 2022, BrainTale, a French MedTech, launched the brainTale-care platform with its modules brainQuant, dedicated to white matter quantification and brainScore-coma, offering the prediction of coma recovery. This launch provides neurologists and resuscitators with clinically verified solutions to enhance the monitoring of the progression of neurological diseases, influencing the decision-making process to optimize patient treatment.
Therefore, the neurology segment is expected to grow over the forecast period due to factors such as the high burden of neurological diseases and rising company activities.
Understand The Key Trends Shaping This Market
Download PDF
The Cardiology Segment is Expected to Record a Significant Market Share Over the Forecast Period
The cardiology segment is expected to witness a significant market share in the patient monitoring market in France over the forecast period owing to factors such as the rising burden of cardiovascular disease and its risk-associated factors, as well as the growing adoption of cardiac monitoring devices.
Cardiac monitoring refers to the continuous or intermittent monitoring of heart activity by assessing the patient's condition relative to cardiac rhythm. Additional monitoring components allow cardiovascular pressures and cardiac output to be monitored and displayed as required for patient diagnosis and treatment.
The rising prevalence of hypertension, stroke, diabetes, obesity, and other cardiovascular diseases is the key factor driving the demand for cardiac patient monitoring equipment, hence bolstering segment growth. For instance, an article published in Dovepress in January 2022 observed that the incidence of myocardial infarction among the population living in France may double by 2035.
In addition to the above context, younger women are expected to suffer more from myocardial infarction than men. Thus, the expected increase in the population suffering from heart disease is anticipated to fuel the demand for cardiac monitoring devices to further reduce the risk of heart failure, propelling the segment's growth.
Additionally, obesity is considered to be a significant public health problem, leading to cardiac complications and increasing the need for patient monitoring devices in the country. For instance, according to the Obesity Atlas data released in March 2023, French adults face a concerning trend. The forecast predicts an obesity rate of 34% by 2035. This heightened risk of obesity not only raises the likelihood of cardiac diseases but also leads to a surge in the adoption of patient monitoring devices, consequently fueling growth in this segment through the forecast period.
Moreover, the increase in funding for developing monitoring devices that are used for detecting and monitoring heart conditions is also expected to bolster segment growth. For instance, in April 2022, Implicity raised EUR 21 million (USD 22.37 million) in Series A funding from Crédit Mutuel Innovation and Bpifrance. With this funding, the company was expected to speed up the international rollout of its AI-based technology and cardiac data management solutions. Therefore, owing to factors such as the rising burden of obesity, coupled with cardiovascular diseases and new funding, the cardiology segment is expected to grow over the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
France Patient Monitoring Industry Overview
The French patient monitoring market is fragmented, with several major players. These players are developing innovative portable patient monitoring devices and launching them in various countries, including France. Some of the major players in the market include Draegerwerk AG, GE Healthcare, Koninklijke Philips NV, Kalstein France, Medtronic PLC, Kaptalia, Baxter International (Hill Rom Holdings), Siemens Healthineers, and Beckton, Dickinson & Company.
France Patient Monitoring Market Leaders
-
Kapatalia
-
Koninklijke Philips NV
-
Kalstein France
-
GE Healthcare
-
Baxter International (Hill Rom Holdings)
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
France Patient Monitoring Market News
- October 2023: OMRON Healthcare Co. Ltd launched the AliveCor KardiaMobile portable ECG to the French market through a distributorship agreement with AliveCor Inc.
- March 2023: OMRON Healthcare, a prominent player in manufacturing home health monitoring medical equipment, signed a strategic partnership with Servier Laboratories, a French non-profit foundation. The collaboration's primary goal is to drive innovations enhancing the identification, management, and sustained control of hypertension and other cardiovascular ailments.
France Patient Monitoring Industry Segmentation
As per the scope of this report, patient monitoring devices are the monitoring devices that continuously monitor the patient's vital parameters, such as blood pressure and heart rate, using a medical monitor. These devices help collect medical (and other) data from individuals.
The French patient monitoring market is segmented by device type, application, and end user. By device type, the market is segmented into hemodynamic monitoring devices, neuromonitoring devices, cardiac monitoring devices, respiratory monitoring devices, and other monitoring devices. By application, the market is segmented into cardiology, neurology, respiratory, fetal and neonatal, weight management and fitness monitoring, and other applications. By end user, the market is segmented into home healthcare, hospitals, and other end users. The report offers market sizes and forecasts in terms of value (USD) for the above segments.
| By Device Type | Hemodynamic Monitoring Devices |
| Neuromonitoring Devices | |
| Cardiac Monitoring Devices | |
| Respiratory Monitoring Devices | |
| Other Types of Devices | |
| By Application | Cardiology |
| Neurology | |
| Respiratory | |
| Fetal and Neonatal | |
| Weight Management and Fitness Monitoring | |
| Other Applications | |
| By End User | Home Healthcare |
| Hospitals | |
| Other End Users |
By Device Type
| Hemodynamic Monitoring Devices |
| Neuromonitoring Devices |
| Cardiac Monitoring Devices |
| Respiratory Monitoring Devices |
| Other Types of Devices |
By Application
| Cardiology |
| Neurology |
| Respiratory |
| Fetal and Neonatal |
| Weight Management and Fitness Monitoring |
| Other Applications |
By End User
| Home Healthcare |
| Hospitals |
| Other End Users |
Need A Different Region or Segment?
Customize Now
France Patient Monitoring Market Research FAQs
How big is the France Patient Monitoring Market?
The France Patient Monitoring Market size is expected to reach USD 2.51 billion in 2025 and grow at a CAGR of 8.01% to reach USD 3.68 billion by 2030.
What is the current France Patient Monitoring Market size?
In 2025, the France Patient Monitoring Market size is expected to reach USD 2.51 billion.
Who are the key players in France Patient Monitoring Market?
Kapatalia, Koninklijke Philips NV, Kalstein France, GE Healthcare and Baxter International (Hill Rom Holdings) are the major companies operating in the France Patient Monitoring Market.
What years does this France Patient Monitoring Market cover, and what was the market size in 2024?
In 2024, the France Patient Monitoring Market size was estimated at USD 2.31 billion. The report covers the France Patient Monitoring Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the France Patient Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on: February 27, 2025
France Patient Monitoring Industry Report
Statistics for the 2025 France Patient Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. France Patient Monitoring analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
